New players in cytokine control of HIV infection

Current HIV/AIDS Reports

Volumn 5, Issue 1, 2008, Pages 27-32

  Alfano, Massimo ^b   Crotti, Andrea ^b   Vicenzi, Elisa ^b   Poli, Guido ^a  

^a P2 P3 Laboratories   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 7; VIRUS DNA;

ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; MACROPHAGE; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; PROTEIN FUNCTION; T LYMPHOCYTE; VIRUS ENTRY; VIRUS REPLICATION; VIRUS TRANSMISSION;

CYTOKINES; HIV INFECTIONS; HIV-1; HUMANS; VIRUS REPLICATION;

EID: 41649089392     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-008-0005-5     Document Type: Article

References (50)

1. Alfano M, Poli G: Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Mol Immunol 2005, 42:161-82.
2. Meanwell NA, Kadow JF: Maraviroc, a chemokine CCR5 receptor antagonist for the treatment of HIV infection and AIDS. Curr Opin Investig Drugs 2007, 8:669-681. Updated state-of-art on CCR5 antagonist in HIV therapy.
3. Selliah N, Zhang M, DeSimone D, et al.: The gamma- cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells. Virology 2006, 344:283-291. Description of a novel transcription factor influencing HIV expression.
4. Crotti A, Lusic M, Lupo R, et al.: Naturally occurring C-terminally truncated STAT5 is a negative regulator of human immunodeficiency virus-type 1 expression. Blood 2007, 109:5380-5389. Description of a novel transcription factor influencing HIV expression.
5. Schmitt N, Nugeyre MT, Scott-Algara D, et al.: Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection. AIDS 2006, 20:533-542.
6. Managua EZ, Landay A, Al-Harthi L: Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway. Virology 2006, 350:443-452. Description of the molecular mechanism triggered by IL-7 enhancing HIV expression.
7. + T cells of individuals with HIV infection.
8. Vassena L, Proschan M, Fauci AS, Lusso P: Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals. Proc Natl Acad Sci U S A 2007, 104:2355-2360.
9. Audige A, Schlaepfer E, Joller H, Speck RF: Uncoupled anti-HIV and immune-enhancing effects when combining IFN-alpha and IL-7. J Immunol 2005, 175:3724-3736.
10. Song H, Nakayama EE, Shioda T: Effects of human interleukin 7 on HIV-1 replication in monocyte-derived human macrophages. AIDS 2006, 20:937-939.
11. Zhang M, Drenkow J, Lankford CS, et al.: HIV regulation of the IL-7R: a viral mechanism for enhancing HIV-1 replication in human macrophages in vitro. J Leukoc Biol 2006, 79:1328-1338.
12. Lum JJ, Schnepple DJ, Nie Z, et al.: Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity. J Virol 2004, 78:6033-6042.
13. Kopka J, Mecikovsky D, Aulicino PC, et al.: High IL-7 plasma levels may induce and predict the emergence of HIV-1 virulent strains in pediatric infection. J Clin Virol 2005, 33:237-242.
14. Lin YL, Portales P, Segondy M, et al.: CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains. J Acquir Immune Defic Syndr 2005, 39:530-536.
15. Rodriguez AR, Arulanandam BP, Hodara VL, et al.: Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees. J Gen Virol 2007, 88:641-651.
16. Bolesta E, Kowalczyk A, Wierzbicki A, et al.: Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery. J Immunol 2006, 177:177-191. Important contribution on the use of cytokines as novel vaccine adjuvants.
17. + T-cell function.
18. + T cells of individuals with HIV infection.
19. Mueller YM, Petrovas C, Bojczuk PM, et al.: Interleukin-15 increases effector memory CD8+ T cells and NK cells in simian immunodeficiency virus-infected macaques. J Virol 2005, 79:4877-4885.
20. Chong SY, Egan MA, Kutzler MA, et al.: Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine 2007, 25:4967-4982.
21. Hryniewicz A, Price DA, Moniuszko M, et al.: Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. J Immunol 2007, 178:3492-3504.
22. Forcina G, d'Ettorre G, Mastroianni CM, et al.: Interleukin-15 modulates interferon-gamma and beta-chemokine production in patients with HIV infection: implications for immune-based therapy. Cytokine 2004, 25:283-290.
23. Biancotto A, Grivel JC, Iglehart SJ, et al.: Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 2007, 109:4272-2479. Important paper showing induction of γc-cytokines from histocultures of lymphoid tissue of individuals with HIV infection.
24. Mueller YM, Bojczuk PM, Halstead ES, et al: IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood 2003, 101:1024-1029.
25. Mastroianni CM, d'Ettorre G, Forcina G, et al.: Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection. Blood 2000, 96:1979-1984.
26. Stopak KS, Chiu YL, Kropp J, et al.: Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem 2007, 282:3539-3546. Important study linking cytokine regulation and APOBEC3G anti-HIV effect.
27. Bettelli E, Korn T, Kuchroo VK: Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007, [Epub ahead of print].
28. Ye P, Rodriguez FH, Kanaly S, et al.: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001, 194:519-527.
29. Maek ANW, Buranapraditkun S, Klaewsongkram J, Ruxrungtham K: Increased interleukin-17 production both in helper T cell subset Th17 and CD4-negative T cells in human immunodeficiency virus infection. Viral Immunol 2007, 20:66-75.
30. Bradney CP, Sempowski GD, Liao HX, et al.: Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization. J Virol 2002, 76:517-524.
31. Billaut-Mulot O, Idziorek T, Loyens M, et al.: Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost. Vaccine 2001, 19:2803-2811.
32. Sailer CA, Pott GB, Dinarello CA, et al: Whole-blood interleukin-18 level during early HIV-1 infection is associated with reduced CXCR4 coreceptor expression and interferon- gamma levels. J Infect Dis 2007, 195:734-738.
33. Tornero C, Alberola J, Tamarit A, Navarro D: Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals. Clin Microbiol Infect 2006, 12:555-560.
34. Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz D: Plasma interleukin-18 is associated with viral load and disease progression in HIV-1-infected patients. Microbes Infect 2004, 6:1273-1277.
35. Lindegaard B, Hansen AB, Pilegaard H, et al.: Adipose tissue expression of IL-18 and HIV-associated lipodystrophy. AIDS 2004, 18:1956-1958.
36. Lindegaard B, Hansen AB, Gerstoft J, Pedersen BK: High plasma level of interleukin-18 in HIV-infected subjects with lipodystrophy. J Acquir Immune Defic Syndr 2004, 36:588-593.
37. Falasca K, Manigrasso MR, Racciatti D, et al.: Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. Ann Clin Lab Sci 2006, 36:59-66.
38. von Giesen HJ, Jander S, Koller H, Arendt G: Serum and cerebrospinal fluid levels of interleukin-18 in human immunodeficiency virus type 1-associated central nervous system disease. J Neurovirol 2004, 10:383-386.
39. Ahmad R, Sindhu ST, Toma E, et al.: Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis. J Virol 2002, 76:12448-12456.
40. Ahmad R, Iannello A, Samarani S, et al.: Contribution of platelet activation to plasma IL-18 concentrations in HIV-infected AIDS patients. AIDS 2006, 20:1907-1909.
41. Pugliese A, Vidotto V, Beltramo T, Torre D: Regulation of interleukin-18 by THP-1 monocytoid cells stimulated with HIV-1 and Nef viral protein. Eur Cytokine Netw 2005, 16:186-190.
42. Shapiro L, Puren AJ, Barton HA, et al.: Interleukin 18 stimulates HIV type 1 in monocytic cells. Proc Natl Acad Sci U S A 1998, 95:12550-12555.
43. Torre D, Pugliese A, Speranza F, et al.: Role of interleukin-18 in human immunodeficiency virus type 1 infection. J Infect Dis 2002, 185:998-999.
44. Choi HJ, Dinarello CA, Shapiro L: Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells. J Infect Dis 2001, 184:560-568.
45. Sabat R, Wallace E, Endesfelder S, Wolk K: IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases. Expert Opin Ther Targets 2007, 11:601-612.
46. Bettaccini AA, Baj A, Accolla RS, et al.: Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes. BMC Microbiol 2005, 5:20.
47. Brandt K, Singh PB, Bulfone-Paus S, Ruckert R: Interleukin-21: a new modulator of immunity, infection, and cancer. Cytokine Growth Factor Rev 2007, 18:223-232.
48. Kastelein RA, Hunter CA, Cua DJ: Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007, 25:221-242.
49. Lapenta C, Santini SM, Spada M, et al.: IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens. Eur J Immunol 2006, 36:2046-2060.
50. Fakruddin JM, Lempicki RA, Gorelick RJ, et al.: Non-infectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. Blood 2007, 109:1841-1849. Important study showing induction of antiviral cytokines and IFNs by VLP.